Expression of Alzheimer-Type Neurofibrillary Epitopes in Primary Rat Cortical Neurons Following Infection with Enterococcus faecalis by Robert Underly et al.
ORIGINAL RESEARCH
published: 20 January 2016
doi: 10.3389/fnagi.2015.00259
Expression of Alzheimer-Type
Neurofibrillary Epitopes in Primary
Rat Cortical Neurons Following
Infection with Enterococcus faecalis
Robert Underly 1, Mee-Sook Song 2, Gary L. Dunbar 2,3 and Charles L. Weaver 4*
1 Department of Psychology, Saginaw Valley State University, University Center, MI, USA, 2 Field Neurosciences Institute,
Saginaw, MI, USA, 3 Department of Psychology, Central Michigan University, Mount Pleasant, MI, USA, 4 Department of
Health Sciences, Saginaw Valley State University, University Center, MI, USA
Edited by:
Fernanda Laezza,
University of Texas Medical Branch,
USA
Reviewed by:
Ramesh Kandimalla,
Emory University, USA
Judith Miklossy,
Prevention Alzheimer International
Foundation and International
Alzheimer Research Center,
Switzerland
*Correspondence:
Charles L. Weaver
clweave1@svsu.edu
Received: 11 September 2015
Accepted: 24 December 2015
Published: 20 January 2016
Citation:
Underly R, Song M-S, Dunbar GL
and Weaver CL (2016) Expression of
Alzheimer-Type Neurofibrillary
Epitopes in Primary Rat Cortical
Neurons Following Infection with
Enterococcus faecalis.
Front. Aging Neurosci. 7:259.
doi: 10.3389/fnagi.2015.00259
The neurofibrillary tau pathology and amyloid deposits seen in Alzheimer’s disease (AD)
also have been seen in bacteria-infected brains. However, few studies have examined
the role of these bacteria in the generation of tau pathology. One suggested link between
infection and AD is edentulism, the complete loss of teeth. Edentulism can result from
chronic periodontal disease due to infection by Enterococcus faecalis. The current study
assessed the ability to generate early Alzheimer-like neurofibrillary epitopes in primary
rat cortical neurons through bacterial infection by E. faecalis. Seven-day old cultured
neurons were infected with E. faecalis for 24 and 48 h. An upward molecular weight
shift in tau by Western blotting (WB) and increased appearance of tau reactivity in cell
bodies and degenerating neurites was found in the 48 h infection group for the antibody
CP13 (phospho-Serine 202). A substantial increase in reactivity of Alz-50 was seen at
24 and 48 h after infection. Furthermore, extensive microtubule-associated protein 2
(MAP2) reactivity also was seen at 24 and 48 h post-infection. Our preliminary findings
suggest a potential link between E. faecalis infection and intracellular changes that may
help facilitate early AD-like neurofibrillary pathology.
Highlights
• Enterococcus faecalis used in the generation of AD neurofibrillary epitopes in rat.
• Infection increases Alz-50, phospho-Serine 202 tau, and MAP2 expression.
• Infection by Enterococcus may play a role in early Alzheimer neurofibrillary changes.
Keywords: Alzheimer’s disease, Enterococcus faecalis, edentulism, chronic periodontitis, tau, phosphorylation,
Alz-50
INTRODUCTION
Neurofibrillary tau pathology and beta amyloid deposition are the classic defining biological
markers of Alzheimer’s disease (AD). The appearance and spread of neurofibrillary tangles
and amyloid plaques have been shown to correlate with the onset and severity of Alzheimer-
type cognitive decline (Braak and Braak, 1995; Sperling et al., 2011). Although these pathological
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hallmarks have been studied extensively, a mechanism for their
onset in AD has yet to be elucidated. During the past three
decades, studies have re-examined the presence of bacterial
infection in AD brains. Various types of spirochetes, including
six periodontal pathogen spirochetes and Borrelia burgdorferi
(MacDonald, 1986; MacDonald and Miranda, 1987; Miklossy,
1993; Riviere et al., 2002; Miklossy et al., 2004) and an obligate
intracellular bacterium Chlamydophila (Chlamydia) pneumoniae
(Balin et al., 1998, 2008; Hammond et al., 2010) have been
detected and isolated from Alzheimer brain tissue, yet few
studies have examined the involvement of these pathogens in the
production of AD-like tau/neurofibrillary pathology (Miklossy
et al., 2006).
The relationship between chronic periodontitis and AD has
been shown with respect to periodontal pathogens (Treponema
denticola, Tannerella forsythia, and Porphyromonas gingivalis)
and their virulence factors (Poole et al., 2013, 2015; Singhrao
et al., 2014). Infection from Enterococcus faecalis, the bacteria
most commonly associated with failed endodontic procedures
(Sundqvist et al., 1998; Rocas et al., 2004; Zoletti et al.,
2006; Al-Ahmad et al., 2010), secondary endodontic infections
(Schirrmeister et al., 2009), urinary tract infections (Zoletti
et al., 2006) and nosocomial infection (Courvalin, 2006),
also has been implicated in the pathogenesis of chronic
periodontitis (Sun et al., 2012). These bacteria can form
biofilms, making them extremely difficult to remove and
allowing for cell microcolony formation which results in
chronic infection (Mohamed and Huang, 2007; Arciola et al.,
2008). Edentulism, the complete loss of teeth, also has been
shown to be present in a subset of individuals with AD
or cerebral atherosclerotic pathologies (Gallo et al., 2005);
and has chronic periodontitis as its most common factor.
Lastly, it has been suggested that E. faecalis can travel from
sites of dental infection to the brain (Mylona et al., 2012);
thus making it an attractive candidate associated with AD
pathology.
To address if early AD-like neurofibrillary epitopes could
be generated by infection with E. faecalis, we examined
potential posttranslational modifications of tau in primary rat
cortical neuron cell cultures after infection with E. faecalis.
Antibodies recognizing conformational change (Alz-50) and
phosphorylation (CP13) of tau were used to detect these epitopes
after the addition of bacteria. This study demonstrates that
E. faecalis increases both Alz-50 and CP13 reactivity, as well
as that of microtubule-associated protein 2 (MAP2), in cortical
cultured neurons; and provides support for the hypothesis
that bacterial infection may play a potential role in Alzheimer
pathology.
MATERIALS AND METHODS
Bacterial Preparation and Primary
Neuronal Cultures
Enterococcus faecalis (ATCC 29212) was cultured in 7 ml of
brain-heart infusion (BHI) broth in 15 ml conical tubes, and was
maintained in an incubator, separate from the neuronal cultures.
The bacteria were stored at 37◦C in a 5% CO2-humidified
incubator. Primary cortical neurons from day-18 Fisher 344 rat
embryos (Cat. #A10840, Gibco/Invitrogen) were cultured on
poly-d-lysine coated 6- and 12-well cell culture plates to a density
of 1.7 × 105 and 8.3 × 104 per well, respectively. Neurons were
plated using Neurobasal medium with 2% B27, 1% Penicillin-
Streptomycin, 0.5% fetal goat serum (FGS), and 0.5 mM
GlutaMax (Cat. #35050, Gibco/Invitrogen). Cells were grown
at 37◦C in a 5% CO2-humidified incubator with media being
changed every 3–4 days. Seven-day old cultured neurons were
infected with E. faecalis, with the final concentration of bacteria
per well being 7 × 106 bacteria/ml. Neurons were harvested
for immunohistochemistry (IHC) and Western blotting (WB) at
24 and 48 h post-infection time points. Experiments were run in
triplicate.
Antibodies
Primary antibodies recognizing pathological changes in
tau (Alz-50, conformation; and CP13, phospho-Serine 202;
generous gift from Dr. Peter Davies, Albert Einstein College
of Medicine) were used for IHC and WB. Anti-β-tubulin
(Cat. # ab5392, Abcam) and anti-MAP2 (Cat. #ab56676,
Abcam) primary antibodies were used as controls in WB
and IHC, respectively. The anti-tubulin antibody was used
to standardize protein levels; and for lack of availability of a
suitable commercial rat-specific pan-tau antibody that provides
consistent staining of tau. Horseradish peroxidase (HRP)-
labeled secondary antibodies (Southern Biotech, Birmingham,
AL, USA) were used for WB, and fluorescence-labeled secondary
antibodies (Molecular Probes, Invitrogen) were used for
IHC.
Western Blot
Cell lysates were analyzed by SDS–PAGE and Western blot.
Briefly, cells were washed with tris-buffered saline (TBS) and
solubilized in ice-cold lysis buffer (50 mM Tris, pH 7.4,
5 mM EDTA, 150 mM NaCl, 1 × ProteaseArrest and
1 × PhosphataseArrest [GBiosciences, St. Louis, MO, USA])
containing 1% SDS. Cells immediately were scraped off the plates
and transferred to a microcentrifuge tube. After centrifugation,
sample buffer was added to the supernatant in an equal volume,
and the entire sample was heated at 100◦C for 5 min. Proteins
were separated in SDS-PAGE (10% polyacrylamide gels; Bio Rad,
Hercules, CA, USA) and transferred onto 0.45 µm nitrocellulose
membranes. Membranes were blocked in 5% fat-free milk in
TBS (milk), and incubated with primary antibodies overnight at
4◦C (1:200 for Alz-50, CP13, and tubulin). An enhanced and
optimized 4-chloronaphthal (Opti-4CN, Cat. # 170-8235, Bio
Rad) detection procedure was then used. Procedures for the non-
infection group were always performed first to avoid accidental
contamination.
Immunohistochemistry
A general IHC double-labeling technique was performed using
the previously mentioned primary antibodies. Cells plated in
12-well culture plates (one control plate and one infected plate)
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with poly-d-lysine coated coverslips were fixed using 10%
buffered formalin. Anti-tau primary antibodies (Alz-50 and
CP13; 1:200 dilution) and anti-MAP2 (control; 1:1000 dilution)
were added individually to their specified wells and allowed to
incubate at 4◦C for 24 h. After washes in TBS, primary antibodies
were removed and secondary antibodies were added in a
dark room to avoid loss of fluorescence. Secondary antibodies
(1:500 dilution for all) were removed, and after additional
washes in TBS, coverslips were mounted and prepared for
confocal fluorescent microscopy analysis (Olympus FluoView
FV10i).
Total Volume Quantification of Alz-50
Imaging of antibody-labeled cells was performed using
an Olympus confocal microscope and FV-1000 software.
Due to the presence of Alz-50-positive cells in young rat
brain (Byne et al., 1991), a method for determining total
volume of Alz-50 expression, with or without infection,
was needed. Volume images from the confocal 3D data
sets were processed with IMARIS software (Bitplane AG,
Zurich, Switzerland). Briefly, in order to avoid bias in the
volume quantification, regions of interest were selected on a
similar grid pattern with the same number and location of
regions for each slide being analyzed. Images were opened
individually and within the z-stack image, a position 1/3 of
the way through the stack was selected. This position (field)
remained constant for all images being analyzed. After the
appropriate fluorescence channel was selected, absolute and
lower threshold intensities were set. Volume data were collected
through the entire cell by the software, and values given in
µm3. Data were exported into Microsoft Excel, and used
in an independent samples t-test. Files were coded so that
groups were not known to the researcher performing the
analysis.
RESULTS
Increased Alz-50, CP13, and MAP2
Reactivity Following Infection
Immunocytochemistry revealed Alz-50 and CP13 reactivity
in cell bodies of neurons in control cultures. Alz-50
and CP13 reactivity increased after the introduction
of E. faecalis in primary rat cortical neuron cultures.
Numerous degenerating (beaded) neurites as well as whole
cell bodies were labeled with Alz-50, both 24 and 48 h
post-infection (Figure 1). Immunostaining revealed similar
changes in the location and abundance of CP13 labeling
48 h post-infection (Figure 2). There was nearly complete
absence of CP13 labeling at 24 h. MAP2 immunoreactivity
of many neurons was also increased at 48 h post-infection
compared to control cells. An independent samples t-test
was used to determine the difference in amounts of
Alz-50 reactivity between control and infected cells at
two time points (Figure 3). Analyses demonstrated a
significant increase (p < 0.001; Fields examined: control
N = 14, infection N = 21) in Alz-50 reactivity 24 h
FIGURE 1 | Substantially increased amounts of Alz-50 and MAP2
reactivity were induced in primary rat cortical neurons by exposure to
Enterococcus faecalis. MAP2 (control-green) and Alz-50 (red) staining can
be seen in both 24 h (A–C) and 48 h (G–I) control cultures (C,I,
co-localization). Alz-50 reactivity was apparent in the cell bodies of neurons in
control cultures, and confirms that its expression can be found in rat neurons.
A striking increase in Alz-50 reactivity was found at both 24 and 48 h
post-infection (E,K respectively). Extensive MAP2 reactivity also was seen
48 h post-infection (J), but not at 24 h post-infection (D). Co-localization of
MAP2 and Alz-50 staining at 24 and 48 h post-infection is shown in (F,L),
respectively. The beaded neurites shown in (J–L) are abundant, and may be
indicative of degeneration. Scale bar in L = 20 µm.
post-infection when compared to the 24 h control.
A significant increase (p = 0.003; Fields examined: control
N = 24, infection N = 15) in Alz-50 reactivity was also
demonstrated 48 h post-infection, when compared to the 48 h
control.
Mobility Shift in Phospho-Tau after
Infection
Western blot analysis revealed a loss of CP13 reactivity at
24 h post-infection, and a restoration of reactivity with an
upwards molecular weight shift in tau at 48 h post-infection
(Figure 4). A similar shift was not seen with the Tubulin
control. Immunoblotting failed to yield any reactivity using
Alz-50.
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FIGURE 2 | In vitro phospho-Serine 202 expression (CP13 reactivity)
was increased in primary rat cortical neurons 48 h after exposure to
E. faecalis. MAP2 and CP13 reactivities were seen in the cell body of neurons
in control cultures (A,B, respectively), with co-localization demonstrated in (C).
Robust CP13 staining was found throughout the cell bodies and degenerating
neurites of neurons post-infection (E). Increased immunoreactivity of MAP2 in
infected neurons compared to control cells was also revealed (D). MAP2 and
CP13 post-infection co-localization is shown in (F). CP13 reactivity was lost
24 h post-infection (data not shown). Scale bar in F = 20 µm.
DISCUSSION
Spirochetes, a phylogenetically distinct group of bacteria,
have been detected and isolated in Alzheimer brain tissue.
Several types of spirochetes were detected in the AD brain
(reviewed by Miklossy, 2011a), including six periodontal
pathogen spirochetes: Treponema (T). denticola, T. socranskii,
T. pectinovorum, T. amylovorum, T. maltophilum, and
T. medium (Riviere et al., 2002) and the Lyme disease spirochete
B. burgdorferi (MacDonald and Miranda, 1987), which was
shown to induce β-amyloid (Aβ) deposits and increased level
of phosphorylated tau successfully in neuronal cell cultures
(Miklossy et al., 2006). In vivo studies using intranasal injection
of an obligate intracellular bacterium such as C. pneumoniae
have been shown to induce beta amyloid deposition in the
brains of BALB/c mice (Little et al., 2004). More recently,
additional association between periodontal pathogens and AD
has been demonstrated (Poole et al., 2013, 2015; Singhrao
et al., 2014), along with the association between chronic
periodontitis and amyloid load (Kamer et al., 2015). Several
extensive reviews of the literature have also reinforced the
significant association between AD and detectable evidence
of infection (Miklossy, 2011b; Maheshwari and Eslick, 2015;
Shoemark and Allen, 2015). Together, these studies suggest
a correlation between Alzheimer’s pathology and bacterial
infection in brain. Pertinent to the present study, a potential link
between oral health and AD has been reviewed by Azaroazhooh
et al. (2010). A study by Gatz et al. (2006) demonstrated that
substantial tooth loss prior to the age of 35 was a significant
risk factor for the development of dementia and AD. Two
studies suggested that edentulous patients, not using dentures,
were at higher risk for either dementia (Kim et al., 2007) or
FIGURE 3 | The appearance of Alz-50 labeling of neurons in control
cultures necessitated a comparison of intensities found between
control and infected plates. Alz-50 staining is found in both control and
infected cultures, with significantly more reactivity found at both 24 (A) and
48 h (B) after the introduction of the E. faecalis. ∗∗∗Represents p < 0.001 (A),
p = 0.003 (B).
mortality (Shimazaki et al., 2001). An inverse association was
also found between having a low number of teeth and dementia
with an absence of the ApoE4 allele (Stein et al., 2007). These
studies, along with the personal observation of numerous
edentulous AD patients, ultimately led to the examination
of whether the powerful dental pathogen, E. faecalis, might
induce the biological markers of AD in vitro, which would
indicate the potential role of this bacterium in AD pathology.
The authors concede, that in the case of positive results, future
studies showing more direct evidence of the link between the
two is needed. Examination for the remnants of E. faecalis in
brains of edentulous and non-edentulous (with severe on-going
periodontal disease) AD patients obviously is the first step;
and human AD tissue recently has been secured for analysis
by the authors. Of particular interest would be those who
experienced edentulism due to advanced caries, failed root canal
therapy, or untreatable/refractory periodontal disease since
enterococci have been demonstrated in these ailments (Kinsel
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FIGURE 4 | Immunoblot of CP13 and tubulin reactivity in primary rat
cortical neurons. CP13 staining of control samples reveals a tau isoform
around 50 kDa (A,B; lane 1 [L1]). There is a distinct loss of CP13 reactivity in
samples at 24 h post-infection (A; lane 2 [L2]). Blotting of samples at 48 h
post-infection demonstrates an upwards shift in mobility of CP13-reactive tau
(B; lane 2 [L2]) . The shift in mobility may be the result of increased
phosphorylation leading to conformational changes in the protein which
causes delayed migration through the gel. β-tubulin was used as a loading
control for the amount of protein loaded per lane (C). L1 and L2 reveal
β-tubulin staining from control and 24 h post-infection samples, while L3 and
L4 reveal β-tubulin staining from control and 48 h post-infection samples.
and Lamb, 2001; Sedgley et al., 2004, 2005; Balaei-Gajan et al.,
2010; Kouidhi et al., 2011). Nevertheless, the present study
further suggests that agents involved in the pathogenesis of
chronic periodontal disorders and edentulism may be related
to Alzheimer’s pathology; since E. faecalis in vitro can influence
the production of pathological epitopes similar to that seen early
in AD.
Antibodies recognizing conformational change (Alz-50) and
specific phosphorylations of tau protein (CP13; phospho-Serine
202) have been shown to label pre-tangle neurons; and therefore,
are suitable markers of early signs of Alzheimer’s degeneration
(Jicha et al., 1997; Weaver et al., 2001; Andorfer et al., 2003,
2005). IHC, performed post-infection, revealed morphological
changes in the form of neuritic beading, as well as the increased
presence of Alz-50 and CP13 reactivity throughout the entire cell.
Because of E. faecalis’ strong virulence, infected neurons tend not
to survive in culture much longer than 60 h; so these neurons
were harvested at 24 and 48 h post-infection. No changes in
reactivity were seen in control samples, which were maintained
in culture for 4 weeks.
The Nature of Alz-50 Reactivity
Alz-50 has been shown to label limited cell populations in
healthy young rat tissue (Byne et al., 1991) which led to
the expectation of finding some Alz-50 reactivity in control
primary rat cortical neurons. Using quantitative total volume
analysis, the amount of reactivity was deciphered in both the
infection and control groups. These data reveal a significant post-
infection increase in Alz-50 reactivity at both 24 and 48 h time
points. This study provides no evidence that bacterial infection
leads to greater amounts of conformational changes of tau.
It does, however, confirm the utility of Alz-50 as a marker
of epitopes normally found in early AD-like degeneration.
Al-Ghoul and Miller (1989) demonstrated Alz-50 labeling in rat
neonatal subplate and cortical neurons prior to their elimination
from the cortex. A subsequent paper from the same group
showed Alz-50 expression in the principal sensory nucleus
following trigeminal nerve lesion (Miller et al., 1994). These
studies suggest that Alz-50 reactivity may be a marker for
neuronal death. A possible substrate reacting with Alz-50 is
the fetal Alz-50 clone 1 (FAC1) protein. Previous studies have
demonstrated that FAC1 is in abundance in the cell bodies and
dendrites of human undifferentiated neurons (Bowser et al.,
1995), and have shown an upregulation in FAC1 expression
after lesioning of intact rodent tissue (Styren et al., 1997). In
the present study, we did not observe Alz-50 reactivity by
immunoblotting; and in fact, achieving Alz-50 reactivity when
using unpurified and unconcentrated primary cortical rat cell
lysate has proven difficult (unpublished raw data). The authors
are only familiar with one study demonstrating significant
Alz-50 reactivity from rat neurons by immunoblotting; and it
was achieved after isolation of the antigen by immunoaffinity
chromatography and subsequent concentration (Al-Ghoul and
Miller, 1989). Regardless of whether the protein involved
is tau or FAC1, it is clear that increased Alz-50 reactivity
with the protein is associated with degeneration of the
neurons.
Phosphorylation Changes after Infection
The CP13 reactivity seen by immunoblotting in control cell
cultures suggests that Serine 202 is normally phosphorylated
in a portion of primary rat cortical neurons. The loss of
reactivity at 24 h and the recovery of signal at 48 h post-
infection together were surprising. However, studies have
shown that oxidative stress, in response to ischemia, can
induce rapid dephosphorylation of tau (Shackelford and
Yeh, 1998), with recovery of the epitope equally rapid for
Serine 202/Threonine 205 (Mailliot et al., 2000). Recent
studies, also, have demonstrated the ability of E. faecalis to
produce oxidative stress through the generation of reactive
oxygen species (Goli´nska et al., 2013; Strickertsson et al.,
2013, 2014). Therefore, it may be possible that the bacteria
caused local ischemic conditions in the culture dish. Since
CP13 is a phosphorylation- and sequence-dependent antibody,
dephosphorylation at Serine 202 will result in loss of reactivity.
[Note: C.Weaver is the co-generator of the CP13 antibody
with P. Davies] The upward molecular weight shift of the
tau band in the infection cultures suggests an increase in
phosphorylation of tau that may lead to conformational
changes that effectively reduces its migration through the
acrylamide gel (Lindwall and Cole, 1984; Bretteville et al., 2009).
Phosphorylation at one site (Ser 202) may not be enough to
generate conformational change in tau. However, it is likely
that multiple sites are being phosphorylated since glycogen
synthase kinase 3 Alpha and Beta (GSK3α and 3β), microtubule-
associated protein kinase 13 (MAPK13), cyclin-dependent kinase
5/p25 (CDK-5/p25), and a host of others can simultaneously
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phosphorylate Ser 202, Thr 231, Ser 235, and Ser 396/404
(Cavallini et al., 2013). The authors only demonstrated one
tau band at 48 h post-infection. It is possible that there
would be two bands of tau after re-phosphorylation and
subsequent increased phosphorylation. The primary author’s
research facilities did not house a film developer, so enhanced
chemilluminescence (ECL) was not utilized. The Opti-4CN
used in the present study may not have been sensitive enough
to display a second tau band similar to that found from
control samples. Along with the increase in immunostaining
throughout the neurites, it is clear that CP13 reactivity
increased as a result of infection. To optimize material for
immunoblotting, volume analyses were not performed for CP13
reactivity.
MAP2 and Neurodegeneration
The use of MAP2 as a control marker for primary rat neurons
is well documented. Increases in MAP2 staining post-infection
were not expected, but are not unreasonable. In AD tissue,
MAP2 staining can be found in dystrophic neurites (Neve
et al., 1986; Trojanowski et al., 1991; Ashford et al., 1998).
While protein levels of MAP2 do not change significantly
in AD, its immunoreactivity in rat neuronal cell cultures
has been shown to increase in response to serum from AD
patients, particularly at 48 h post-application (Brewer and
Ashford, 1992). The results of increased MAP2 reactivity and
morphological changes to neurites, in this study, provide support
for neuritic reorganization and degeneration in this cell culture
model.
Aβ42 and Enterococcus faecalis
A recent study has shown that Aβ42 functions as an antimicrobial
peptide (AMP) that expresses activity against E. faecalis (Soscia
et al., 2010). The group demonstrated that Aβ42 was present at
significantly greater levels in the temporal lobe of AD patients
compared to age-matched non-AD brains. These findings
suggest that increased levels of Aβ42 in AD brain tissue could
be due to an immune response of Aβ42 to an infection-inducing
microorganism present in the tissue. These data lend support to
the idea that the pathology seen in AD could be related to an
infectious agent.
CONCLUSION
These preliminary data suggest that pathologic epitopes
generated in early AD may be influenced by infection with
E. faecalis. While the nature of the type of protein eliciting
Alz-50 reactivity is unknown, it is important to recognize that
reactivity is significantly increased after infection. As a result,
further research on the implications of bacterial infection and
AD is warranted.
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